| Year |
Citation |
Score |
| 2023 |
El-Achkar TM, Eadon MT, Kretzler M, Himmelfarb J. Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 37839688 DOI: 10.1053/j.ajkd.2023.08.015 |
0.344 |
|
| 2023 |
Chang SY, Huang W, Chapron A, Quiñones AJL, Wang J, Isoherranen N, Shen DD, Kelly EJ, Himmelfarb J, Yeung CK. Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease. Pharmaceutical Research. PMID 37704895 DOI: 10.1007/s11095-023-03594-x |
0.317 |
|
| 2023 |
Sharma K, Zhang G, Hansen J, Bjornstad P, Lee HJ, Menon R, Hejazi L, Liu JJ, Franzone A, Looker HC, Choi BY, Fernandez R, Venkatachalam MA, Kugathasan L, Sridhar VS, ... ... Himmelfarb J, et al. Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients. The Journal of Clinical Investigation. PMID 37616058 DOI: 10.1172/JCI170341 |
0.305 |
|
| 2023 |
Sharma K, Zhang G, Hansen J, Bjornstad P, Lee HJ, Menon R, Hejazi L, Liu JJ, Franzone A, Looker HC, Choi BY, Fernandez R, Venkatachalam MA, Kugathasan L, Sridhar VS, ... ... Himmelfarb J, et al. Role of endogenous adenine in kidney failure and mortality with diabetes. Medrxiv : the Preprint Server For Health Sciences. PMID 37398187 DOI: 10.1101/2023.05.31.23290681 |
0.304 |
|
| 2021 |
Jaramillo-Morales J, Korucu B, Pike MM, Lipworth L, Stewart TG, Headley SA, Germain M, Begue G, Roshanravan B, Tuttle KR, Himmelfarb J, Robinson-Cohen C, Ikizler TA, Gamboa JL. Effects of caloric restriction and aerobic exercise on circulating cell-free mitochondrial DNA in patients with moderate-to-severe chronic kidney disease. American Journal of Physiology. Renal Physiology. PMID 34843657 DOI: 10.1152/ajprenal.00270.2021 |
0.557 |
|
| 2021 |
Ikizler TA, Himmelfarb J. Chronic Kidney Disease Rescuing kidney patients from early demise: Role of anti-cytokine therapies. Kidney International. PMID 34302849 DOI: 10.1016/j.kint.2021.07.011 |
0.306 |
|
| 2021 |
Wang K, Zelnick LR, Chertow GM, Himmelfarb J, Bansal N. Body Composition Changes Following Dialysis Initiation and Cardiovascular and Mortality Outcomes in CRIC (Chronic Renal Insufficiency Cohort): A Bioimpedance Analysis Substudy. Kidney Medicine. 3: 327-334.e1. PMID 34136778 DOI: 10.1016/j.xkme.2020.12.008 |
0.301 |
|
| 2021 |
MacLaughlin HL, Pike M, Selby NM, Siew E, Chinchilli VM, Guide A, Stewart TG, Himmelfarb J, Go AS, Parikh CR, Ghahramani N, Kaufman J, Ikizler TA, Robinson-Cohen C. Body mass index and chronic kidney disease outcomes after acute kidney injury: a prospective matched cohort study. Bmc Nephrology. 22: 200. PMID 34049502 DOI: 10.1186/s12882-021-02400-3 |
0.62 |
|
| 2021 |
de Boer IH, Alpers CE, Azeloglu EU, Balis UGJ, Barasch JM, Barisoni L, Blank KN, Bomback AS, Brown K, Dagher PC, Dighe AL, Eadon MT, El-Achkar TM, Gaut JP, Hacohen N, ... ... Himmelfarb J, et al. Rationale and design of the Kidney Precision Medicine Project. Kidney International. 99: 498-510. PMID 33637194 DOI: 10.1016/j.kint.2020.08.039 |
0.356 |
|
| 2020 |
Pike MM, Alsouqi A, Headley SAE, Tuttle K, Evans EE, Milch CM, Moody KA, Germain M, Stewart TG, Lipworth L, Himmelfarb J, Ikizler TA, Robinson-Cohen C. The Authors Reply. Kidney International Reports. 5: 2405-2406. PMID 33305144 DOI: 10.1016/j.ekir.2020.09.029 |
0.456 |
|
| 2020 |
Puthumana J, Thiessen-Philbrook H, Xu L, Coca SG, Garg AX, Himmelfarb J, Bhatraju PK, Ikizler TA, Siew E, Ware LB, Liu KD, Go AS, Kaufman JS, Kimmel PL, Chinchilli VM, et al. Biomarkers of inflammation and repair in kidney disease progression. The Journal of Clinical Investigation. PMID 33290282 DOI: 10.1172/JCI139927 |
0.32 |
|
| 2020 |
Ong E, Wang LL, Schaub J, O'Toole JF, Steck B, Rosenberg AZ, Dowd F, Hansen J, Barisoni L, Jain S, de Boer IH, Valerius MT, Waikar SS, Park C, Crawford DC, ... ... Himmelfarb J, et al. Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project. Nature Reviews. Nephrology. PMID 32939051 DOI: 10.1038/S41581-020-00335-W |
0.402 |
|
| 2020 |
Imaoka T, Yang J, Wang L, McDonald MG, Afsharinejad Z, Bammler TK, Van Ness K, Yeung CK, Rettie AE, Himmelfarb J, Kelly EJ. Microphysiological System Modeling of Ochratoxin A-Associated Nephrotoxicity. Toxicology. 152582. PMID 32905824 DOI: 10.1016/J.Tox.2020.152582 |
0.399 |
|
| 2020 |
Pike MM, Alsouqi A, Headley SAE, Tuttle K, Evans EE, Milch CM, Moody KA, Germain M, Stewart TG, Lipworth L, Himmelfarb J, Ikizler TA, Robinson-Cohen C. Supervised Exercise Intervention and Overall Activity in CKD. Kidney International Reports. 5: 1261-1270. PMID 32775825 DOI: 10.1016/J.Ekir.2020.06.006 |
0.599 |
|
| 2020 |
Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nature Reviews. Nephrology. PMID 32733095 DOI: 10.1038/S41581-020-0315-4 |
0.347 |
|
| 2020 |
Bhatraju PK, Wurfel MM, Himmelfarb J. Trajectory of Kidney Function: The Canary in Sepsis. American Journal of Respiratory and Critical Care Medicine. PMID 32716638 DOI: 10.1164/Rccm.202007-2627Ed |
0.37 |
|
| 2020 |
Ikizler TA, Parikh CR, Himmelfarb J, Chinchilli VM, Liu KD, Coca SG, Garg AX, Hsu CY, Siew ED, Wurfel MM, Ware LB, Faulkner GB, Tan TC, Kaufman JS, Kimmel PL, et al. A prospective cohort study that examined acute kidney injury and kidney outcomes, cardiovascular events and death informs on long-term clinical outcomes. Kidney International. PMID 32707221 DOI: 10.1016/J.Kint.2020.06.032 |
0.432 |
|
| 2020 |
Bhatraju PK, Cohen M, Nagao RJ, Morrell ED, Kosamo S, Chai XY, Nance R, Dmyterko V, Delaney J, Christie JD, Liu KD, Mikacenic C, Gharib SA, Liles WC, Zheng Y, ... ... Himmelfarb J, et al. Genetic variation implicates plasma angiopoietin-2 in the development of acute kidney injury sub-phenotypes. Bmc Nephrology. 21: 284. PMID 32680471 DOI: 10.1186/S12882-020-01935-1 |
0.345 |
|
| 2020 |
Himmelfarb J, Ratner B. Wearable artificial kidney: problems, progress and prospects. Nature Reviews. Nephrology. PMID 32612282 DOI: 10.1038/S41581-020-0318-1 |
0.358 |
|
| 2020 |
Aydemir N, Pike MM, Alsouqi A, Headley SAE, Tuttle K, Evans EE, Milch CM, Moody KA, Germain M, Lipworth L, Himmelfarb J, Ikizler TA, Robinson-Cohen C. Effects of diet and exercise on adipocytokine levels in patients with moderate to severe chronic kidney disease. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. PMID 32571614 DOI: 10.1016/J.Numecd.2020.04.012 |
0.633 |
|
| 2020 |
Kestenbaum B, Gamboa J, Liu S, Ali AS, Shankland E, Jue T, Giulivi C, Smith LR, Himmelfarb J, de Boer IH, Conley K, Roshanravan B. Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease. Jci Insight. 5. PMID 32161192 DOI: 10.1172/Jci.Insight.133289 |
0.35 |
|
| 2020 |
Wang K, Nguyen M, Chen Y, Hoofnagle AN, Becker JO, Zelnick LR, Kundzins J, Goodling A, Himmelfarb J, Kestenbaum B. Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 32152064 DOI: 10.2215/Cjn.11120919 |
0.372 |
|
| 2020 |
Shum S, Imaoka T, Huang W, Chang S, Yeung C, Himmelfarb J, Kelly E, Isoherranen N. Predicting renal clearance of morphine and morphine‐6‐glucuronide using the “organ‐on‐a‐chip” technology and physiologically‐based pharmacokinetic modeling The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04121 |
0.308 |
|
| 2020 |
Imaoka T, Shum S, Chang S, Chapron A, Yeung CK, Himmelfarb J, Isoherranen N, Kelly EJ. P7 - Utilization of a microphysiological system to model renal secretion of opioids in humans Drug Metabolism and Pharmacokinetics. 35. DOI: 10.1016/J.Dmpk.2020.04.008 |
0.301 |
|
| 2019 |
Wang K, Zelnick LR, Hoofnagle AN, Chen Y, de Boer IH, Himmelfarb J, Kestenbaum B. Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 31347660 DOI: 10.1093/Ndt/Gfz144 |
0.428 |
|
| 2019 |
Hsu CY, Hsu RK, Liu KD, Yang J, Anderson A, Chen J, Chinchilli VM, Feldman HI, Garg AX, Hamm L, Himmelfarb J, Kaufman JS, Kusek JW, Parikh CR, Ricardo AC, et al. Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts. Journal of the American Society of Nephrology : Jasn. PMID 31235617 DOI: 10.1681/Asn.2018101036 |
0.397 |
|
| 2019 |
Kubiak RW, Zelnick LR, Hoofnagle AN, Alpers CE, Terry CM, Shiu YT, Cheung AK, de Boer IH, Robinson-Cohen C, Allon M, Dember LM, Feldman HI, Himmelfarb J, Huber TS, Roy-Chaudhury P, et al. Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. PMID 31000459 DOI: 10.1016/J.Ejvs.2019.01.022 |
0.598 |
|
| 2019 |
Bhatraju PK, Zelnick LR, Katz R, Mikacenic C, Kosamo S, Hahn WO, Dmyterko V, Kestenbaum B, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM. A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 30917991 DOI: 10.2215/Cjn.04100318 |
0.313 |
|
| 2019 |
Siebenthall KT, Miller CP, Vierstra JD, Mathieu J, Tretiakova M, Reynolds A, Sandstrom R, Rynes E, Haugen E, Johnson A, Nelson J, Bates D, Diegel M, Dunn D, Frerker M, ... ... Himmelfarb J, et al. Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma. Ebiomedicine. PMID 30827930 DOI: 10.1016/J.Ebiom.2019.01.063 |
0.32 |
|
| 2019 |
Limkunakul C, de Boer IH, Kestenbaum BR, Himmelfarb J, Ikizler TA, Robinson-Cohen C. The association of glycated hemoglobin with mortality and ESKD among persons with diabetes and chronic kidney disease. Journal of Diabetes and Its Complications. PMID 30795915 DOI: 10.1016/J.Jdiacomp.2018.12.010 |
0.641 |
|
| 2019 |
Alam ML, Katz R, Bellovich KA, Bhat ZY, Brosius FC, de Boer IH, Gadegbeku CA, Gipson DS, Hawkins JJ, Himmelfarb J, Kestenbaum BR, Kretzler M, Robinson-Cohen C, Steigerwalt SP, Tuegel C, et al. Soluble ST2 and Galectin-3 and Progression of CKD. Kidney International Reports. 4: 103-111. PMID 30596173 DOI: 10.1016/J.Ekir.2018.09.013 |
0.649 |
|
| 2019 |
Bhatraju P, Russell J, Walley K, Liles W, Himmelfarb J, Wurfel M. 1455: Acute Kidney Injury Subphenotypes Respond Differently To Vasopressin Therapy In Septic Shock Critical Care Medicine. 47: 704. DOI: 10.1097/01.Ccm.0000552199.19977.39 |
0.339 |
|
| 2018 |
Weber EJ, Lidberg KA, Wang L, Bammler TK, MacDonald JW, Li MJ, Redhair M, Atkins WM, Tran C, Hines KM, Herron J, Xu L, Monteiro MB, Ramm S, Vaidya V, ... ... Himmelfarb J, et al. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. Jci Insight. 3. PMID 30568031 DOI: 10.1172/Jci.Insight.123673 |
0.34 |
|
| 2018 |
Rayner SG, Phong KT, Xue J, Lih D, Shankland SJ, Kelly EJ, Himmelfarb J, Zheng Y. Reconstructing the Human Renal Vascular-Tubular Unit In Vitro. Advanced Healthcare Materials. e1801120. PMID 30379416 DOI: 10.1002/Adhm.201801120 |
0.37 |
|
| 2018 |
Hiraki HL, Nagao RJ, Himmelfarb J, Zheng Y. Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel. Journal of Visualized Experiments : Jove. PMID 30371659 DOI: 10.3791/58314 |
0.307 |
|
| 2018 |
Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, Morrell ED, Robinson-Cohen C, Calfee CS, Christie JD, Liu KD, Matthay MA, Hahn WO, Dmyterko V, Slivinski NSJ, ... ... Himmelfarb J, et al. Identification of Acute Kidney Injury Sub-phenotypes with Differing Molecular Signatures and Response to Vasopressin Therapy. American Journal of Respiratory and Critical Care Medicine. PMID 30334632 DOI: 10.1164/Rccm.201807-1346Oc |
0.599 |
|
| 2018 |
Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, Gamboa JL, Utzschneider K, Kestenbaum B, Himmelfarb J, Kahn SE, Raftery D, de Boer IH. Chronic kidney disease attenuates the plasma metabolome response to insulin. Jci Insight. 3. PMID 30135309 DOI: 10.1172/Jci.Insight.122219 |
0.309 |
|
| 2018 |
Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM, Imrey PB, Robinson-Cohen C, de Boer IH, Shiu YT, Himmelfarb J, Beck GJ, Kestenbaum B. Alteration of HDL Protein Composition with Hemodialysis Initiation. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 30045914 DOI: 10.2215/Cjn.11321017 |
0.579 |
|
| 2018 |
Chapron BD, Chapron A, Phillips B, Okoli MC, Shen DD, Kelly EJ, Himmelfarb J, Thummel KE. Reevaluating the role of megalin in renal vitamin D homeostasis using a human cell-derived microphysiological system. Altex. PMID 29999169 DOI: 10.14573/Altex.1803161 |
0.304 |
|
| 2018 |
Trivedi R, Fares G, Nunez VB, Campbell R, Clement M, Burleson J, Himmelfarb J, Ioannidou E. Novel PAradigm to improve Inflammatory burden in end stage Renal disease (rePAIR): study protocol for a randomized controlled trial. Trials. 19: 370. PMID 29996883 DOI: 10.1186/S13063-018-2760-Y |
0.367 |
|
| 2018 |
Bansal N, Zelnick LR, Himmelfarb J, Chertow GM. Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29885923 DOI: 10.1053/J.Ajkd.2018.03.030 |
0.383 |
|
| 2018 |
Tuegel C, Katz R, Alam M, Bhat Z, Bellovich K, de Boer I, Brosius F, Gadegbeku C, Gipson D, Hawkins J, Himmelfarb J, Ju W, Kestenbaum B, Kretzler M, Robinson-Cohen C, et al. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29866459 DOI: 10.1053/J.Ajkd.2018.03.025 |
0.649 |
|
| 2017 |
Himmelfarb J, Chertow GM, McCullough PA, Mesana T, Shaw AD, Sundt TM, Brown C, Cortville D, Dagenais F, de Varennes B, Fontes M, Rossert J, Tardif JC. Perioperative THR-184 and AKI after Cardiac Surgery. Journal of the American Society of Nephrology : Jasn. PMID 29203473 DOI: 10.1681/Asn.2017020217 |
0.335 |
|
| 2017 |
Bansal N, Matheny ME, Greevy RA, Eden SK, Perkins AM, Parr SK, Fly J, Abdel-Kader K, Himmelfarb J, Hung AM, Speroff T, Ikizler TA, Siew ED. Acute Kidney Injury and Risk of Incident Heart Failure Among US Veterans. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29162339 DOI: 10.1053/J.Ajkd.2017.08.027 |
0.405 |
|
| 2017 |
Young BA, Fullerton SM, Wilson JG, Cavanaugh K, Blacksher E, Spigner C, Himmelfarb J, Burke W. Clinical Genetic Testing for APOL1: Are we There Yet? Seminars in Nephrology. 37: 552-557. PMID 29110763 DOI: 10.1016/J.Semnephrol.2017.07.009 |
0.346 |
|
| 2017 |
Weber EJ, Himmelfarb J, Kelly EJ. Concise Review: Current and Emerging Biomarkers of Nephrotoxicity. Current Opinion in Toxicology. 4: 16-21. PMID 29057384 DOI: 10.1016/J.Cotox.2017.03.002 |
0.381 |
|
| 2017 |
Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J. Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial. Journal of the American Society of Nephrology : Jasn. PMID 29038285 DOI: 10.1681/Asn.2017010020 |
0.603 |
|
| 2017 |
Cruz NM, Song X, Czerniecki SM, Gulieva RE, Churchill AJ, Kim YK, Winston K, Tran LM, Diaz MA, Fu H, Finn LS, Pei Y, Himmelfarb J, Freedman BS. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nature Materials. PMID 28967916 DOI: 10.1038/Nmat4994 |
0.329 |
|
| 2017 |
Bhatraju PK, Robinson-Cohen C, Mikacenic C, Harju-Baker S, Dmyterko V, Slivinski NSJ, Liles WC, Himmelfarb J, Heckbert SR, Wurfel MM. Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype. Critical Care (London, England). 21: 217. PMID 28814331 DOI: 10.1186/S13054-017-1807-X |
0.642 |
|
| 2017 |
Rubinow KB, Henderson CM, Robinson-Cohen C, Himmelfarb J, de Boer IH, Vaisar T, Kestenbaum B, Hoofnagle AN. Kidney function is associated with an altered protein composition of high-density lipoprotein. Kidney International. PMID 28754556 DOI: 10.1016/J.Kint.2017.05.020 |
0.624 |
|
| 2017 |
Cardenas-Gonzalez M, Srivastava A, Pavkovic M, Bijol V, Rennke HG, Stillman IE, Zhang X, Parikh S, Rovin BH, Afkarian M, de Boer IH, Himmelfarb J, Waikar SS, Vaidya VS. Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy. Clinical Chemistry. PMID 28667184 DOI: 10.1373/Clinchem.2017.274175 |
0.439 |
|
| 2017 |
Mikacenic C, Price BL, Harju-Baker S, O'Mahony DS, Robinson-Cohen C, Radella F, Hahn WO, Katz R, Christiani DC, Himmelfarb J, Liles WC, Wurfel MM. A Two Biomarker Model Predicts Mortality in the Critically Ill with Sepsis. American Journal of Respiratory and Critical Care Medicine. PMID 28418697 DOI: 10.1164/Rccm.201611-2307Oc |
0.578 |
|
| 2017 |
Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, ... ... Himmelfarb J, et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. Journal of the American Society of Nephrology : Jasn. PMID 28408440 DOI: 10.1681/Asn.2016050562 |
0.346 |
|
| 2017 |
van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YE, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 28359657 DOI: 10.1053/J.Ajkd.2017.01.049 |
0.338 |
|
| 2017 |
Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, et al. Growth Differentiation Factor-15 and Risk of CKD Progression. Journal of the American Society of Nephrology : Jasn. PMID 28159780 DOI: 10.1681/Asn.2016080919 |
0.653 |
|
| 2016 |
Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J. Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27927588 DOI: 10.1053/J.Ajkd.2016.08.041 |
0.627 |
|
| 2016 |
Bowlby W, Zelnick LR, Henry C, Himmelfarb J, Kahn SE, Kestenbaum B, Robinson-Cohen C, Utzschneider KM, de Boer IH. Physical activity and metabolic health in chronic kidney disease: a cross-sectional study. Bmc Nephrology. 17: 187. PMID 27876008 DOI: 10.1186/S12882-016-0400-X |
0.649 |
|
| 2016 |
Bhatraju PK, Mukherjee P, Robinson-Cohen C, O'Keefe GE, Frank AJ, Christie JD, Meyer NJ, Liu KD, Matthay MA, Calfee CS, Christiani DC, Himmelfarb J, Wurfel MM. Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death. Critical Care (London, England). 20: 372. PMID 27852290 DOI: 10.1186/S13054-016-1546-4 |
0.644 |
|
| 2016 |
Liu KD, Siew ED, Reeves WB, Himmelfarb J, Go AS, Hsu CY, Bennett MR, Devarajan P, Ikizler TA, Kaufman JS, Kimmel PL, Chinchilli VM, Parikh CR. Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study. Plos One. 11: e0164832. PMID 27788160 DOI: 10.1371/Journal.Pone.0164832 |
0.352 |
|
| 2016 |
Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R. Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27637132 DOI: 10.1053/J.Ajkd.2016.06.024 |
0.405 |
|
| 2016 |
Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M, Streja E, Himmelfarb J, Mehrotra R. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease. Kidney International. PMID 27555118 DOI: 10.1016/J.Kint.2016.06.028 |
0.364 |
|
| 2016 |
Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK. Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients. Plos One. 11: e0161074. PMID 27513517 DOI: 10.1371/Journal.Pone.0161074 |
0.635 |
|
| 2016 |
Nagao RJ, Xu J, Luo P, Xue J, Wang Y, Kotha S, Zeng W, Fu X, Himmelfarb J, Zheng Y. Decellularized human kidney cortex hydrogels enhance kidney microvascular endothelial cell maturation and quiescence. Tissue Engineering. Part A. PMID 27481445 DOI: 10.1089/Ten.Tea.2016.0213 |
0.388 |
|
| 2016 |
Dember LM, Imrey PB, Duess MA, Hamburg NM, Larive B, Radeva M, Himmelfarb J, Kraiss LW, Kusek JW, Roy-Chaudhury P, Terry CM, Vazquez MA, Vongpatanasin W, Beck GJ, Vita JA, et al. Vascular Function at Baseline in the Hemodialysis Fistula Maturation Study. Journal of the American Heart Association. 5. PMID 27451463 DOI: 10.1161/Jaha.116.003227 |
0.379 |
|
| 2016 |
Gura V, Rivara MB, Bieber S, Munshi R, Smith NC, Linke L, Kundzins J, Beizai M, Ezon C, Kessler L, Himmelfarb J. A wearable artificial kidney for patients with end-stage renal disease. Jci Insight. 1. PMID 27398407 DOI: 10.1172/Jci.Insight.86397 |
0.371 |
|
| 2016 |
Robinson-Cohen C, Katz R, Price BL, Harju-Baker S, Mikacenic C, Himmelfarb J, Liles WC, Wurfel MM. Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients. Critical Care (London, England). 20: 207. PMID 27372077 DOI: 10.1186/S13054-016-1385-3 |
0.63 |
|
| 2016 |
Afkarian M, Katz R, Bansal N, Correa A, Kestenbaum B, Himmelfarb J, de Boer IH, Young B. Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27340284 DOI: 10.2215/Cjn.13111215 |
0.339 |
|
| 2016 |
Roshanravan B, Kestenbaum B, Gamboa J, Jubrias SA, Ayers E, Curtin L, Himmelfarb J, de Boer IH, Conley KE. CKD and Muscle Mitochondrial Energetics. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27312460 DOI: 10.1053/J.Ajkd.2016.05.011 |
0.301 |
|
| 2016 |
Xie Y, Maziarz M, Tuot DS, Chertow GM, Himmelfarb J, Hall YN. Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study. Bmc Nephrology. 17: 57. PMID 27276913 DOI: 10.1186/S12882-016-0272-0 |
0.413 |
|
| 2016 |
Bansal N, Katz R, Himmelfarb J, Afkarian M, Kestenbaum B, de Boer IH, Young B. Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 27257276 DOI: 10.1093/Ndt/Gfw218 |
0.382 |
|
| 2016 |
Gamboa JL, Billings FT, Bojanowski MT, Gilliam LA, Yu C, Roshanravan B, Roberts LJ, Himmelfarb J, Ikizler TA, Brown NJ. Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease. Physiological Reports. 4. PMID 27162261 DOI: 10.14814/Phy2.12780 |
0.373 |
|
| 2016 |
Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, Frendl G, Himmelfarb J, Waikar SS, Vaidya VS. Detection of Drug-induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c and -423. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27122240 DOI: 10.1093/Toxsci/Kfw077 |
0.607 |
|
| 2016 |
Young BA, Katz R, Boulware LE, Kestenbaum B, de Boer IH, Wang W, Fülöp T, Bansal N, Robinson-Cohen C, Griswold M, Powe NN, Himmelfarb J, Correa A. Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27066930 DOI: 10.1053/J.Ajkd.2016.02.046 |
0.626 |
|
| 2016 |
Rivara MB, Soohoo M, Streja E, Molnar MZ, Rhee CM, Cheung AK, Katz R, Arah OA, Nissenson AR, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R. Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26728588 DOI: 10.2215/Cjn.06570615 |
0.314 |
|
| 2016 |
Ikizler HO, Zelnick L, Ruzinski J, Curtin L, Utzschneider KM, Kestenbaum B, Himmelfarb J, de Boer IH. Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 26: 93-102. PMID 26508542 DOI: 10.1053/J.Jrn.2015.08.008 |
0.341 |
|
| 2015 |
Ligresti G, Nagao RJ, Xue J, Choi YJ, Xu J, Ren S, Aburatani T, Anderson SK, MacDonald JW, Bammler TK, Schwartz SM, Muczynski KA, Duffield JS, Himmelfarb J, Zheng Y. A Novel Three-Dimensional Human Peritubular Microvascular System. Journal of the American Society of Nephrology : Jasn. PMID 26657868 DOI: 10.1681/Asn.2015070747 |
0.317 |
|
| 2015 |
Suchy-Dicey AM, Laha T, Hoofnagle A, Newitt R, Sirich TL, Meyer TW, Thummel KE, Yanez ND, Himmelfarb J, Weiss NS, Kestenbaum BR. Tubular Secretion in CKD. Journal of the American Society of Nephrology : Jasn. PMID 26614381 DOI: 10.1681/Asn.2014121193 |
0.438 |
|
| 2015 |
Mikacenic C, Hahn WO, Price BL, Harju-Baker S, Katz R, Kain KC, Himmelfarb J, Liles WC, Wurfel MM. Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness. Plos One. 10: e0141251. PMID 26492036 DOI: 10.1371/Journal.Pone.0141251 |
0.311 |
|
| 2015 |
Bhatraju P, Hsu C, Mukherjee P, Glavan BJ, Burt A, Mikacenic C, Himmelfarb J, Wurfel M. Associations between single nucleotide polymorphisms in the FAS pathway and acute kidney injury. Critical Care (London, England). 19: 368. PMID 26477820 DOI: 10.1186/S13054-015-1084-5 |
0.324 |
|
| 2015 |
Craciun FL, Bijol V, Ajay AK, Rao P, Kumar RK, Hutchinson J, Hofmann O, Joshi N, Luyendyk JP, Kusebauch U, Moss CL, Srivastava A, Himmelfarb J, Waikar SS, Moritz RL, et al. RNA Sequencing Identifies Novel Translational Biomarkers of Kidney Fibrosis. Journal of the American Society of Nephrology : Jasn. PMID 26449608 DOI: 10.1681/Asn.2015020225 |
0.394 |
|
| 2015 |
Afkarian M, Zelnick LR, Ruzinski J, Kestenbaum B, Himmelfarb J, de Boer IH, Mehrotra R. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes. Journal of Diabetes and Its Complications. 29: 1024-31. PMID 26412030 DOI: 10.1016/J.Jdiacomp.2015.08.024 |
0.363 |
|
| 2015 |
Thomas B, Wulf S, Bikbov B, Perico N, Cortinovis M, Courville de Vaccaro K, Flaxman A, Peterson H, Delossantos A, Haring D, Mehrotra R, Himmelfarb J, Remuzzi G, Murray C, Naghavi M. Maintenance Dialysis throughout the World in Years 1990 and 2010. Journal of the American Society of Nephrology : Jasn. 26: 2621-33. PMID 26209712 DOI: 10.1681/Asn.2014101017 |
0.377 |
|
| 2015 |
Rivara MB, Ikizler TA, Ellis CD, Mehrotra R, Himmelfarb J. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients. Bmc Nephrology. 16: 79. PMID 26045064 DOI: 10.1186/S12882-015-0074-9 |
0.317 |
|
| 2015 |
Shao B, de Boer I, Tang C, Mayer PS, Zelnick L, Afkarian M, Heinecke JW, Himmelfarb J. A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects. Journal of Proteome Research. 14: 2792-806. PMID 26011469 DOI: 10.1021/Acs.Jproteome.5B00060 |
0.333 |
|
| 2015 |
Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Brunelli S, Heagerty PJ, Katz R, Molnar MZ, Nissenson A, Ravel V, Streja E, Himmelfarb J, Mehrotra R. Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 1208-17. PMID 25883196 DOI: 10.1093/Ndt/Gfv097 |
0.367 |
|
| 2015 |
Roshanravan B, Patel KV, Robinson-Cohen C, de Boer IH, O'Hare AM, Ferrucci L, Himmelfarb J, Kestenbaum B. Creatinine clearance, walking speed, and muscle atrophy: a cohort study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 65: 737-47. PMID 25542415 DOI: 10.1053/J.Ajkd.2014.10.016 |
0.599 |
|
| 2015 |
Maziarz M, Black RA, Fong CT, Himmelfarb J, Chertow GM, Hall YN. Evaluating risk of ESRD in the urban poor. Journal of the American Society of Nephrology : Jasn. 26: 1434-42. PMID 25475746 DOI: 10.1681/Asn.2014060546 |
0.319 |
|
| 2015 |
Rivara MB, Robinson-Cohen C, Kestenbaum B, Roshanravan B, Chen CH, Himmelfarb J, Mehrotra R. Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney disease. Hemodialysis International. International Symposium On Home Hemodialysis. 19: 147-50. PMID 25404416 DOI: 10.1111/Hdi.12244 |
0.632 |
|
| 2015 |
Rivara MB, Mehrotra R, Linke L, Ruzinski J, Ikizler TA, Himmelfarb J. A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 25: 40-9. PMID 25218876 DOI: 10.1053/J.Jrn.2014.07.006 |
0.302 |
|
| 2015 |
Hung AM, Booker C, Ellis CD, Siew ED, Graves AJ, Shintani A, Abumrad NN, Himmelfarb J, Ikizler TA. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 266-74. PMID 25204316 DOI: 10.1093/Ndt/Gfu283 |
0.35 |
|
| 2014 |
Robinson-Cohen C, Hall YN, Katz R, Rivara MB, de Boer IH, Kestenbaum BR, Himmelfarb J. Self-rated health and adverse events in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 9: 2044-51. PMID 25301857 DOI: 10.2215/Cjn.03140314 |
0.593 |
|
| 2014 |
Maziarz M, Chertow GM, Himmelfarb J, Hall YN. Homelessness and risk of end-stage renal disease. Journal of Health Care For the Poor and Underserved. 25: 1231-44. PMID 25130236 DOI: 10.1353/Hpu.2014.0136 |
0.411 |
|
| 2014 |
Charytan DM, Padera R, Helfand AM, Zeisberg M, Xu X, Liu X, Himmelfarb J, Cinelli A, Kalluri R, Zeisberg EM. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease. International Journal of Cardiology. 176: 99-109. PMID 25049013 DOI: 10.1016/J.Ijcard.2014.06.062 |
0.383 |
|
| 2014 |
Himmelfarb J, Tuttle KR. Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease. The New England Journal of Medicine. 370: 1768-9. PMID 24804308 DOI: 10.1056/Nejmc1400872 |
0.325 |
|
| 2014 |
de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, Siscovick DS, Steffes MW, Thummel KE, Tracy RP, Wang Z, et al. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 64: 187-97. PMID 24703961 DOI: 10.1053/J.Ajkd.2014.02.015 |
0.555 |
|
| 2014 |
Claure-Del Granado R, Macedo E, Soroko S, Kim Y, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD). Hemodialysis International. International Symposium On Home Hemodialysis. 18: 641-9. PMID 24620987 DOI: 10.1111/Hdi.12157 |
0.317 |
|
| 2014 |
Mehrotra R, Agarwal A, Bargman JM, Himmelfarb J, Johansen KL, Watnick S, Work J, McBryde K, Flessner M, Kimmel PL. Dialysis therapies: a National Dialogue. Clinical Journal of the American Society of Nephrology : Cjasn. 9: 812-4. PMID 24458085 DOI: 10.2215/Cjn.12601213 |
0.401 |
|
| 2014 |
Himmelfarb J, Ikizler TA, Ellis C, Wu P, Shintani A, Dalal S, Kaplan M, Chonchol M, Hakim RM. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. Journal of the American Society of Nephrology : Jasn. 25: 623-33. PMID 24371300 DOI: 10.1681/Asn.2013050545 |
0.321 |
|
| 2014 |
Robinson-Cohen C, Littman AJ, Duncan GE, Weiss NS, Sachs MC, Ruzinski J, Kundzins J, Rock D, de Boer IH, Ikizler TA, Himmelfarb J, Kestenbaum BR. Physical activity and change in estimated GFR among persons with CKD. Journal of the American Society of Nephrology : Jasn. 25: 399-406. PMID 24335971 DOI: 10.1681/Asn.2013040392 |
0.597 |
|
| 2014 |
Ioannidou E, Swede H, Fares G, Himmelfarb J. Tooth loss strongly associates with malnutrition in chronic kidney disease Journal of Periodontology. 85: 899-907. PMID 24215204 DOI: 10.1902/Jop.2013.130347 |
0.381 |
|
| 2014 |
Khatri M, Himmelfarb J, Adams D, Becker K, Longstreth WT, Tirschwell DL. Acute kidney injury is associated with increased hospital mortality after stroke Journal of Stroke and Cerebrovascular Diseases. 23: 25-30. PMID 22818389 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.06.005 |
0.344 |
|
| 2013 |
Kelly EJ, Wang Z, Voellinger JL, Yeung CK, Shen DD, Thummel KE, Zheng Y, Ligresti G, Eaton DL, Muczynski KA, Duffield JS, Neumann T, Tourovskaia A, Fauver M, Kramer G, ... ... Himmelfarb J, et al. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Research & Therapy. 4: S17. PMID 24564863 DOI: 10.1186/Scrt378 |
0.399 |
|
| 2013 |
Mehrotra R, de Boer IH, Himmelfarb J. Adverse effects of systemic glucose absorption with peritoneal dialysis: how good is the evidence? Current Opinion in Nephrology and Hypertension. 22: 663-8. PMID 24076559 DOI: 10.1097/Mnh.0B013E328365B3D1 |
0.321 |
|
| 2013 |
Mehrotra R, Rivara M, Himmelfarb J. Initiation of dialysis should be timely: neither early nor late. Seminars in Dialysis. 26: 644-9. PMID 24004413 DOI: 10.1111/Sdi.12127 |
0.445 |
|
| 2013 |
Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, TerWee P, Teta D, Wang AY, Wanner C. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney International. 84: 1096-107. PMID 23698226 DOI: 10.1038/Ki.2013.147 |
0.368 |
|
| 2013 |
Roshanravan B, Robinson-Cohen C, Patel KV, Ayers E, Littman AJ, de Boer IH, Ikizler TA, Himmelfarb J, Katzel LI, Kestenbaum B, Seliger S. Association between physical performance and all-cause mortality in CKD. Journal of the American Society of Nephrology : Jasn. 24: 822-30. PMID 23599380 DOI: 10.1681/Asn.2012070702 |
0.614 |
|
| 2013 |
Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. Kidney disease and increased mortality risk in type 2 diabetes. Journal of the American Society of Nephrology : Jasn. 24: 302-8. PMID 23362314 DOI: 10.1681/Asn.2012070718 |
0.347 |
|
| 2013 |
Mehrotra R, Himmelfarb J. Dialysis in 2012: Could longer and more frequent haemodialysis improve outcomes? Nature Reviews. Nephrology. 9: 74-5. PMID 23296294 DOI: 10.1038/Nrneph.2012.287 |
0.382 |
|
| 2013 |
Siew ED, Himmelfarb J. The inexorable rise of AKI: can we bend the growth curve? Journal of the American Society of Nephrology : Jasn. 24: 3-5. PMID 23243210 DOI: 10.1681/Asn.2012111115 |
0.33 |
|
| 2013 |
de Boer IH, Sachs M, Hoofnagle AN, Utzschneider KM, Kahn SE, Kestenbaum B, Himmelfarb J. Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease. Kidney International. 83: 323-30. PMID 22913981 DOI: 10.1038/Ki.2012.311 |
0.377 |
|
| 2013 |
Ioannidou E, Hall Y, Swede H, Himmelfarb J. Periodontitis associated with chronic kidney disease among Mexican Americans. Journal of Public Health Dentistry. 73: 112-9. PMID 22775287 DOI: 10.1111/J.1752-7325.2012.00350.X |
0.393 |
|
| 2013 |
Robinson-Cohen C, Littman AJ, Duncan GE, Roshanravan B, Ikizler TA, Himmelfarb J, Kestenbaum BR. Assessment of physical activity in chronic kidney disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 23: 123-31. PMID 22739659 DOI: 10.1053/J.Jrn.2012.04.008 |
0.617 |
|
| 2012 |
Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B. A prospective study of frailty in nephrology-referred patients with CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 60: 912-21. PMID 22770927 DOI: 10.1053/J.Ajkd.2012.05.017 |
0.637 |
|
| 2012 |
Hall YN, Choi AI, Himmelfarb J, Chertow GM, Bindman AB. Homelessness and CKD: a cohort study. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1094-102. PMID 22700883 DOI: 10.2215/Cjn.00060112 |
0.318 |
|
| 2012 |
Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney International. 82: 693-700. PMID 22648296 DOI: 10.1038/Ki.2012.193 |
0.587 |
|
| 2012 |
Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Toward the optimal dose metric in continuous renal replacement therapy. The International Journal of Artificial Organs. 35: 413-24. PMID 22466995 DOI: 10.5301/Ijao.5000041 |
0.313 |
|
| 2011 |
Himmelfarb J. Optimizing patient safety during hemodialysis. Jama. 306: 1707-8. PMID 22009104 DOI: 10.1001/Jama.2011.1507 |
0.337 |
|
| 2011 |
Thakar CV, Christianson A, Himmelfarb J, Leonard AC. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2567-72. PMID 21903988 DOI: 10.2215/Cjn.01120211 |
0.414 |
|
| 2011 |
Johnson AC, Ware LB, Himmelfarb J, Zager RA. HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2108-13. PMID 21799150 DOI: 10.2215/Cjn.02440311 |
0.363 |
|
| 2011 |
Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. Bmc Medicine. 9: 11. PMID 21288330 DOI: 10.1186/1741-7015-9-11 |
0.378 |
|
| 2011 |
Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel PL, Molitoris BA, Murthy M, O'Hare AM, Schmader KE, High KP. Acute kidney injury in older adults. Journal of the American Society of Nephrology : Jasn. 22: 28-38. PMID 21209252 DOI: 10.1681/Asn.2010090934 |
0.41 |
|
| 2011 |
Ramos LF, Kane J, McMonagle E, Le P, Wu P, Shintani A, Ikizler TA, Himmelfarb J. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 21: 211-8. PMID 21185738 DOI: 10.1053/J.Jrn.2010.08.003 |
0.345 |
|
| 2011 |
Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Medicine. 37: 241-8. PMID 21152901 DOI: 10.1007/S00134-010-2089-9 |
0.417 |
|
| 2011 |
Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 467-75. PMID 21115626 DOI: 10.2215/Cjn.02500310 |
0.32 |
|
| 2011 |
Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM, Himmelfarb J, Zager RA. MCP-1 gene activation marks acute kidney injury. Journal of the American Society of Nephrology : Jasn. 22: 165-75. PMID 21071523 DOI: 10.1681/Asn.2010060641 |
0.397 |
|
| 2011 |
Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Circulation. Heart Failure. 4: 18-26. PMID 21036889 DOI: 10.1161/Circheartfailure.109.932558 |
0.34 |
|
| 2011 |
Granado RC, Macedo E, Soroko S, Kim YW, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL, Martin-Moreno PL, Garcia-Fernandez N, Varo N, Nunez-Cordoba JM, Haase-Fielitz A, Mertens PR, et al. Acute kidney injury / Nephrocalcinosis Ndt Plus. 4. DOI: 10.1093/Ndtplus/4.S2.16 |
0.356 |
|
| 2010 |
Eisenhart E, Benson S, Lacombe P, Himmelfarb J, Zimmerman R, Schimelman B, Parker MG. Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy. Seminars in Dialysis. 23: 638-42. PMID 21175838 DOI: 10.1111/J.1525-139X.2010.00800.X |
0.428 |
|
| 2010 |
Ahmad S, Himmelfarb J. The ABCs of micronutrients in dialysis patients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 56: 431-3. PMID 20728789 DOI: 10.1053/J.Ajkd.2010.07.004 |
0.313 |
|
| 2010 |
Sedor JR, Watnick S, Patel UD, Cheung A, Harmon W, Himmelfarb J, Hostetter TH, Inrig JK, Mehrotra R, Robinson E, Smedberg PC, Shaffer RN. ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. Journal of the American Society of Nephrology : Jasn. 21: 1235-7. PMID 20675502 DOI: 10.1681/Asn.2010060656 |
0.325 |
|
| 2010 |
Nolin TD, Ouseph R, Himmelfarb J, McMenamin ME, Ward RA. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1588-94. PMID 20538838 DOI: 10.2215/Cjn.00210110 |
0.346 |
|
| 2010 |
Macedo E, Bouchard J, Soroko SH, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Critical Care (London, England). 14: R82. PMID 20459609 DOI: 10.1186/Cc9004 |
0.355 |
|
| 2010 |
Young BA, Von Korff M, Heckbert SR, Ludman EJ, Rutter C, Lin EH, Ciechanowski PS, Oliver M, Williams L, Himmelfarb J, Katon WJ. Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. General Hospital Psychiatry. 32: 119-24. PMID 20302984 DOI: 10.1016/J.Genhosppsych.2009.11.018 |
0.353 |
|
| 2010 |
Schröppel B, Krüger B, Walsh L, Yeung M, Harris S, Garrison K, Himmelfarb J, Lerner SM, Bromberg JS, Zhang PL, Bonventre JV, Wang Z, Farris AB, Colvin RB, Murphy BT, et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. Journal of the American Society of Nephrology : Jasn. 21: 536-42. PMID 20019169 DOI: 10.1681/Asn.2009040390 |
0.382 |
|
| 2010 |
Bouchard J, Macedo E, Soroko S, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 102-7. PMID 19679558 DOI: 10.1093/Ndt/Gfp392 |
0.42 |
|
| 2009 |
Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Seminars in Dialysis. 22: 636-43. PMID 20017834 DOI: 10.1111/J.1525-139X.2009.00659.X |
0.346 |
|
| 2009 |
Himmelfarb J. Acute kidney injury in the elderly: problems and prospects. Seminars in Nephrology. 29: 658-64. PMID 20006798 DOI: 10.1016/J.Semnephrol.2009.07.008 |
0.447 |
|
| 2009 |
Khosla N, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini E, Mehta RL. Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 1914-9. PMID 19965524 DOI: 10.2215/Cjn.01690309 |
0.431 |
|
| 2009 |
Himmelfarb J, Shankland SJ. Creating research infrastructure and functionality to address chronic kidney disease: the Kidney Research Institute. Seminars in Nephrology. 29: 457-66. PMID 19751890 DOI: 10.1016/J.Semnephrol.2009.06.002 |
0.398 |
|
| 2009 |
Levin A, Himmelfarb J. Human resources, training, and the growing worldwide epidemic of kidney disease: introduction. Seminars in Nephrology. 29: 455-6. PMID 19751889 DOI: 10.1016/J.Semnephrol.2009.06.001 |
0.303 |
|
| 2009 |
Hakim RM, Himmelfarb J. Hemodialysis access failure: a call to action--revisited. Kidney International. 76: 1040-8. PMID 19710629 DOI: 10.1038/Ki.2009.318 |
0.312 |
|
| 2009 |
Nolin TD, Frye RF, Le P, Sadr H, Naud J, Leblond FA, Pichette V, Himmelfarb J. ESRD impairs nonrenal clearance of fexofenadine but not midazolam. Journal of the American Society of Nephrology : Jasn. 20: 2269-76. PMID 19696225 DOI: 10.1681/Asn.2009010082 |
0.302 |
|
| 2009 |
Anderson S, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kaysen GA, Kusek JW, Nayfield SG, Schmader K, Tian Y, Ashworth JR, Clayton CP, Parker RP, Tarver ED, Woolard NF, et al. Prediction, progression, and outcomes of chronic kidney disease in older adults. Journal of the American Society of Nephrology : Jasn. 20: 1199-209. PMID 19470680 DOI: 10.1681/Asn.2008080860 |
0.437 |
|
| 2009 |
Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney International. 76: 422-7. PMID 19436332 DOI: 10.1038/Ki.2009.159 |
0.402 |
|
| 2009 |
Okamura DM, Himmelfarb J. Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney disease. Pediatric Nephrology (Berlin, Germany). 24: 2309-19. PMID 19421784 DOI: 10.1007/S00467-009-1199-5 |
0.38 |
|
| 2009 |
Ramos LF, Shintani A, Himmelfarb J, Ikizler TA. Determinants of plasma adiponectin levels in nondiabetic subjects with moderate to severe chronic kidney disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 19: 197-203. PMID 19393918 DOI: 10.1053/J.Jrn.2009.01.028 |
0.351 |
|
| 2009 |
Hingorani S, Molitoris BA, Himmelfarb J. Ironing out the pathogenesis of acute kidney injury. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 53: 569-71. PMID 19324244 DOI: 10.1053/J.Ajkd.2009.01.002 |
0.411 |
|
| 2009 |
Szczech LA, Harmon W, Hostetter TH, Klotman PE, Powe NR, Sedor JR, Smedberg P, Himmelfarb J. World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. Journal of the American Society of Nephrology : Jasn. 20: 453-5. PMID 19244576 DOI: 10.1681/Asn.2009010041 |
0.436 |
|
| 2009 |
Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ. Acute kidney injury increases risk of ESRD among elderly. Journal of the American Society of Nephrology : Jasn. 20: 223-8. PMID 19020007 DOI: 10.1681/Asn.2007080837 |
0.459 |
|
| 2008 |
Breggia AC, Himmelfarb J. Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stress. Oxidative Medicine and Cellular Longevity. 1: 33-8. PMID 19794906 DOI: 10.4161/Oxim.1.1.6491 |
0.717 |
|
| 2008 |
Michaud J, Nolin TD, Naud J, Dani M, Lafrance JP, Leblond FA, Himmelfarb J, Pichette V. Effect of hemodialysis on hepatic cytochrome P450 functional expression. Journal of Pharmacological Sciences. 108: 157-63. PMID 18845914 DOI: 10.1254/Jphs.08042Fp |
0.33 |
|
| 2008 |
Breggia AC, Wojchowski DM, Himmelfarb J. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells. American Journal of Physiology. Renal Physiology. 295: F1689-95. PMID 18815218 DOI: 10.1152/Ajprenal.90333.2008 |
0.714 |
|
| 2008 |
Himmelfarb J. Oxidative stress in hemodialysis. Contributions to Nephrology. 161: 132-137. PMID 18451669 DOI: 10.1159/000130658 |
0.32 |
|
| 2008 |
Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D'Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 962-7. PMID 18354074 DOI: 10.2215/Cjn.04971107 |
0.432 |
|
| 2008 |
Davis CL, Harmon WE, Himmelfarb J, Hostetter T, Powe N, Smedberg P, Szczech LA, Aronson PS. World Kidney Day 2008: think globally, speak locally. Journal of the American Society of Nephrology : Jasn. 19: 413-6. PMID 18272837 DOI: 10.1681/Asn.2008010070 |
0.329 |
|
| 2008 |
Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology : Jasn. 19: 593-9. PMID 18256365 DOI: 10.1681/Asn.2007030355 |
0.349 |
|
| 2008 |
Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J. Technology Insight: biomarker development in acute kidney injury--what can we anticipate? Nature Clinical Practice. Nephrology. 4: 154-65. PMID 18227821 DOI: 10.1038/Ncpneph0723 |
0.349 |
|
| 2007 |
Rubin C, Nolin TD, Himmelfarb J. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease? Current Opinion in Nephrology and Hypertension. 16: 506-11. PMID 18089962 DOI: 10.1097/Mnh.0B013E3282F0B331 |
0.406 |
|
| 2007 |
Lacson E, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM. Balancing Fistula First with Catheters Last. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 50: 379-95. PMID 17720517 DOI: 10.1053/J.Ajkd.2007.06.006 |
0.33 |
|
| 2007 |
Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 17: 296-304. PMID 17720098 DOI: 10.1053/J.Jrn.2007.05.011 |
0.329 |
|
| 2007 |
Himmelfarb J. Continuous renal replacement therapy in the treatment of acute renal failure: critical assessment is required. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 385-9. PMID 17699438 DOI: 10.2215/Cjn.02890806 |
0.38 |
|
| 2007 |
Himmelfarb J, Henrich W, DuBose T. Anemia of kidney disease and clinical practice guidelines: Quo Vadis? Clinical Journal of the American Society of Nephrology. 2: 213-214. PMID 17699415 DOI: 10.2215/Cjn.04401206 |
0.305 |
|
| 2007 |
Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. Jama. 297: 2630-3. PMID 17579231 DOI: 10.1001/Jama.297.23.2630 |
0.334 |
|
| 2007 |
Himmelfarb J. Continuous dialysis is not superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nature Clinical Practice. Nephrology. 3: 120-1. PMID 17322925 DOI: 10.1038/Ncpneph0422 |
0.417 |
|
| 2007 |
Himmelfarb J, Kliger AS. End-stage renal disease measures of quality. Annual Review of Medicine. 58: 387-99. PMID 17217331 DOI: 10.1146/Annurev.Med.58.061705.151442 |
0.338 |
|
| 2007 |
Himmelfarb J. Dialytic Therapy in Acute Renal Failure: No Reason for Nihilism Seminars in Dialysis. 9: 230-234. DOI: 10.1111/J.1525-139X.1996.Tb00658.X |
0.345 |
|
| 2006 |
Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clinical Journal of the American Society of Nephrology : Cjasn. 1: 915-9. PMID 17699307 DOI: 10.2215/CJN.01430406 |
0.341 |
|
| 2006 |
Himmelfarb J. Dialysis at a crossroads: reverse engineering renal replacement therapy. Clinical Journal of the American Society of Nephrology : Cjasn. 1: 896-902. PMID 17699302 DOI: 10.2215/Cjn.10911105 |
0.372 |
|
| 2006 |
Cho KC, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, Chertow GM. Survival by dialysis modality in critically ill patients with acute kidney injury. Journal of the American Society of Nephrology : Jasn. 17: 3132-8. PMID 17021268 DOI: 10.1681/Asn.2006030268 |
0.437 |
|
| 2006 |
Chertow GM, Soroko SH, Paganini EP, Cho KC, Himmelfarb J, Ikizler TA, Mehta RL. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney International. 70: 1120-6. PMID 16850028 DOI: 10.1038/Sj.Ki.5001579 |
0.375 |
|
| 2006 |
Ikizler TA, Himmelfarb J. Muscle wasting in kidney disease: Let's get physical. Journal of the American Society of Nephrology : Jasn. 17: 2097-8. PMID 16837638 DOI: 10.1681/Asn.2006060629 |
0.312 |
|
| 2006 |
Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. Journal of the American Society of Nephrology : Jasn. 17: 1135-42. PMID 16495381 DOI: 10.1681/Asn.2005060668 |
0.309 |
|
| 2006 |
Himmelfarb J. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease. Cardiology Clinics. 23: 319-30. PMID 16084281 DOI: 10.1016/J.Ccl.2005.03.005 |
0.335 |
|
| 2005 |
Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 79: 914-9. PMID 15849543 DOI: 10.1097/01.Tp.0000157773.96534.29 |
0.421 |
|
| 2005 |
Boaz M, Iuliano L, Himmelfarb J, Matas Z, Micheletta F, McMonagle E, Friedman V, Natoli S, Gvirtz G, Biro A, Smetana S, Sabo G, Gafter U, Weinstein T. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin E and intima media thickness progression in end-stage renal disease (VIPER) cohort Nephron - Clinical Practice. 100: c111-c119. PMID 15849477 DOI: 10.1159/000085290 |
0.353 |
|
| 2005 |
Basi S, Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S, Chertow GM, Mehta RL, Paganini E, Himmelfarb J, Ikizler TA. Insulin resistance in critically ill patients with acute renal failure. American Journal of Physiology. Renal Physiology. 289: F259-64. PMID 15840772 DOI: 10.1152/Ajprenal.00002.2005 |
0.316 |
|
| 2005 |
Himmelfarb J, Chertow GM. Medicare ESRD prospective payment system: weighing the evidence. Journal of the American Society of Nephrology : Jasn. 16: 1164-5. PMID 15829705 DOI: 10.1681/Asn.2005030315 |
0.328 |
|
| 2005 |
Klenzak J, Himmelfarb J. Sepsis and the kidney. Critical Care Clinics. 21: 211-22. PMID 15781158 DOI: 10.1016/J.Ccc.2005.01.002 |
0.409 |
|
| 2005 |
Himmelfarb J. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg? Seminars in Dialysis. 17: 449-54. PMID 15660575 DOI: 10.1111/J.0894-0959.2004.17605.X |
0.359 |
|
| 2005 |
Himmelfarb J, Le P, Klenzak J, Freedman S, McMenamin ME, Ikizler TA. Impaired monocyte cytokine production in critically ill patients with acute renal failure. Kidney International. 66: 2354-60. PMID 15569326 DOI: 10.1111/J.1523-1755.2004.66023.X |
0.349 |
|
| 2005 |
Himmelfarb J, McMonagle E, Freedman S, Klenzak J, McMenamin E, Le P, Pupim LB, Ikizler TA. Oxidative stress is increased in critically ill patients with acute renal failure. Journal of the American Society of Nephrology : Jasn. 15: 2449-56. PMID 15339994 DOI: 10.1097/01.Asn.0000138232.68452.3B |
0.34 |
|
| 2004 |
Himmelfarb J, Pereira BJ, Wesson DE, Smedberg PC, Henrich WL. Payment for quality in end-stage renal disease. Journal of the American Society of Nephrology : Jasn. 15: 3263-9. PMID 15579531 DOI: 10.1097/01.Asn.0000145893.61791.7B |
0.371 |
|
| 2004 |
Gordon CA, Himmelfarb J. Antioxidant therapy in uremia: Evidence-based medicine? Seminars in Dialysis. 17: 327-332. PMID 15461735 DOI: 10.1111/J.0894-0959.2004.17357.X |
0.382 |
|
| 2004 |
Delmonico FL, Morrissey PE, Lipkowitz GS, Stoff JS, Himmelfarb J, Harmon W, Pavlakis M, Mah H, Goguen J, Luskin R, Milford E, Basadonna G, Chobanian M, Bouthot B, Lorber M, et al. Donor kidney exchanges. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 1628-34. PMID 15367217 DOI: 10.1111/J.1600-6143.2004.00572.X |
0.307 |
|
| 2004 |
Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International. 65: 1357-65. PMID 15086475 DOI: 10.1111/J.1523-1755.2004.00512.X |
0.365 |
|
| 2004 |
Parker TF, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M, Nissenson AR, Pereira B, Weiss J. The chronic kidney disease initiative. Journal of the American Society of Nephrology : Jasn. 15: 708-16. PMID 14978173 DOI: 10.1097/01.Asn.0000112129.20838.3F |
0.391 |
|
| 2004 |
Ikizler TA, Sezer MT, Flakoll PJ, Hariachar S, Kanagasundaram NS, Gritter N, Knights S, Shyr Y, Paganini E, Hakim RM, Himmelfarb J. Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney International. 65: 725-32. PMID 14717948 DOI: 10.1111/J.1523-1755.2004.00439.X |
0.336 |
|
| 2004 |
Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney International. 64: 978-91. PMID 12911548 DOI: 10.1046/J.1523-1755.2003.00151.X |
0.318 |
|
| 2004 |
Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 286-94. PMID 12900810 DOI: 10.1016/S0272-6386(03)00653-X |
0.32 |
|
| 2003 |
Himmelfarb J, Hakim RM. Oxidative stress in uremia. Current Opinion in Nephrology and Hypertension. 12: 593-8. PMID 14564195 DOI: 10.1097/00041552-200311000-00004 |
0.35 |
|
| 2003 |
Chertow GM, Pascual MT, Soroko S, Savage BR, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Reasons for non-enrollment in a cohort study of ARF: the Program to Improve Care in Acute Renal Disease (PICARD) experience and implications for a clinical trials network. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 507-12. PMID 12955678 DOI: 10.1016/S0272-6386(03)00745-5 |
0.375 |
|
| 2002 |
Himmelfarb J. Success and challenge in dialysis therapy. The New England Journal of Medicine. 347: 2068-70. PMID 12490690 DOI: 10.1056/Nejme020146 |
0.401 |
|
| 2001 |
Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients. Free Radical Biology & Medicine. 31: 1163-9. PMID 11705694 DOI: 10.1016/S0891-5849(01)00697-9 |
0.359 |
|
| 2001 |
Himmelfarb J, McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney International. 60: 358-63. PMID 11422772 DOI: 10.1046/J.1523-1755.2001.00807.X |
0.303 |
|
| 2001 |
Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney International. 58: 2571-8. PMID 11115093 DOI: 10.1046/J.1523-1755.2000.00443.X |
0.319 |
|
| 2001 |
Saadeh E, Ikizler T, Shyr Y, Hakim RM, Himmelfarb J. Recombinant human growth hormone in patients with acute renal failure Journal of Renal Nutrition. 11: 212-219. DOI: 10.1016/S1051-2276(01)70040-4 |
0.342 |
|
| 2000 |
Saadeh E, Szatkowski M, Vary CP, Smith JD, Himmelfarb J, Mahoney RJ. HLA-DMA allele polymorphism: no impact on kidney allograft outcome. Human Immunology. 61: 345-7. PMID 10689127 DOI: 10.1016/S0198-8859(99)00178-0 |
0.304 |
|
| 2000 |
Delmonico FL, Milford EL, Goguen J, Harmon WE, Lipkowitz G, Himmelfarb J, Mah H, Fan PY, Rohrer RJ, Lorber MI. A novel united network for organ sharing region kidney allocation plan improves transplant access for minority candidates. Transplantation. 68: 1875-9. PMID 10628767 DOI: 10.1097/00007890-199912270-00010 |
0.306 |
|
| 1999 |
Himmelfarb J. Pharmacologic prevention of vascular access stenosis. Current Opinion in Nephrology and Hypertension. 8: 569-72. PMID 10541219 DOI: 10.1097/00041552-199909000-00006 |
0.304 |
|
| 1994 |
Himmelfarb J, Holbrook D, McMonagle E, Robinson R, Nye L, Spratt D. Kt/V, nutritional parameters, serum cortisol, and insulin growth factor-1 levels and patient outcome in hemodialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 24: 473-9. PMID 8079972 DOI: 10.1016/S0272-6386(12)80904-8 |
0.305 |
|
| 1990 |
Mahoney RJ, Ault KA, Given SR, Adams RJ, Breggia AC, Paris PA, Palomaki GE, Hitchcox SA, White BW, Himmelfarb J. The flow cytometric crossmatch and early renal transplant loss. Transplantation. 49: 527-35. PMID 2138366 DOI: 10.1097/00007890-199003000-00011 |
0.711 |
|
| Show low-probability matches. |